Processa Pharmaceuticals (PCSA) Change in Inventory (2012 - 2015)
Processa Pharmaceuticals' (PCSA) quarterly Change in Inventory came in at $15129.0 in Q4 2015, up 189.64% YoY from $5223.4 in Q4 2014, and up 135.71% on a QoQ basis from -$42367.0 in Q3 2015.
Processa Pharmaceuticals (PCSA) Change in Inventory (2012 - 2015) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 4 years of Change in Inventory data on file, last reported at $15129.0 in Q4 2015.
- Quarterly Change in Inventory rose 189.64% year-over-year to $15129.0 in Q4 2015, while the trailing twelve-month figure through Dec 2015 was -$7065.0 (up 90.33% YoY) and the FY2015 annual result came in at -$7065.0, up 90.33% from the prior year.
- Change in Inventory improved to $15129.0 in Q4 2015, from -$42367.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $60883.0 in Q4 2013 to a low of -$135732.0 in Q2 2013.
- A 4-year average of -$11699.6 and a median of -$2502.0 in 2012 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2013 — Change in Inventory surged 6618.52% — and 2015, when it sank 866.68%.
- Tracing PCSA's Change in Inventory over 4 years: stood at -$934.0 in 2012, then surged by 6618.52% to $60883.0 in 2013, then sank by 127.72% to -$16878.0 in 2014, then soared by 189.64% to $15129.0 in 2015.
- The last three Change in Inventory figures came in at $15129.0 (Q4 2015), -$42367.0 (Q3 2015), and -$4070.0 (Q2 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -280,000.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 12.97 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 135.26 Mn |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 15,129.00 |
| Dec 31, 2015 | 15,129.00 |
| Sep 30, 2015 | -42,367.00 |
| Sep 30, 2015 | -42,367.00 |
| Jun 30, 2015 | -4,070.00 |
| Jun 30, 2015 | -4,070.00 |
| Mar 31, 2015 | 24,243.00 |
| Mar 31, 2015 | 24,243.00 |
| Dec 31, 2014 | -16,878.00 |
| Dec 31, 2014 | -16,878.00 |
| Sep 30, 2014 | 5,526.00 |
| Sep 30, 2014 | 5,526.00 |
| Jun 30, 2014 | 57,503.00 |
| Jun 30, 2014 | 57,503.00 |
| Mar 31, 2014 | -119,236.00 |
| Mar 31, 2014 | -119,236.00 |
| Dec 31, 2013 | 60,883.00 |
| Dec 31, 2013 | 60,883.00 |
| Sep 30, 2013 | -8,629.00 |
| Sep 30, 2013 | -8,629.00 |